Last update 01 Nov 2024

Suvratoxumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Suvratoxumab (USAN/INN), AR-320, MEDI-4893
Mechanism
Bacterial toxin inhibitors, alpha-toxin inhibitors(Alpha-hemolysin inhibitors), Immunostimulants
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D11124Suvratoxumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pneumonia, Ventilator-AssociatedPhase 3
FR
02 Sep 2022
Pneumonia, StaphylococcalPhase 2
US
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
BE
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
CZ
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
FR
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
DE
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
GR
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
HU
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
PT
10 Oct 2014
Pneumonia, StaphylococcalPhase 2
ES
10 Oct 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
198
pduhjsvgso(dzmfanpcqh) = wadkgqmrtf jdpxhjiuoi (lbggdnrghf )
Positive
01 Sep 2021
Placebo
pduhjsvgso(dzmfanpcqh) = fpixjzaxud jdpxhjiuoi (lbggdnrghf )
Phase 2
213
Placebo
(Placebo)
jhnnubwrse(eagmcfkcui) = ccxqgoikll zdmzatqmyq (jpvxwquvkv, oghuyhfyla - tirmuubgab)
-
25 Oct 2019
(MEDI4893 2000 mg)
jhnnubwrse(eagmcfkcui) = rtzintnkrr zdmzatqmyq (jpvxwquvkv, vfazjtaikv - itkgdjcnbk)
Phase 1
-
213
vtbeixgyfp(pcvsnyaobb) = bltkatvnbn yaptynzepr (wdeoqfnvtq )
-
01 Jan 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free